Quercetin — Stack & Timing
Educational timing and stacking information based on how Quercetin has been studied. Not a prescription. Not medical advice.
This is educational information only. Consult a healthcare provider before starting any supplement.
Stack & Timing Guidance
Educational summary based on how Quercetin has been studied and commonly used.
Commonly studied timing
Quercetin is fat-soluble and its bioavailability is meaningfully enhanced when taken with a fat-containing meal; morning dosing with breakfast is commonly recommended in protocols, and pre-workout timing has been explored for attenuation of exercise-induced muscle damage.
Dose ranges used in studies
Clinical studies and meta-analyses have examined doses ranging from approximately 250 mg to 1000 mg daily for cardiovascular and anti-inflammatory outcomes; senolytic research protocols use short intermittent high-dose cycles (e.g., 500 mg twice daily for 2–3 days) rather than continuous dosing, and bioavailability varies substantially by formulation (e.g., quercetin phytosome, quercetin glycosides).
↑ These are ranges from research studies, not personal dosing recommendations. Discuss with a clinician.
Commonly paired with
Quercetin is proposed to act as a zinc ionophore, facilitating intracellular zinc uptake; this combination is highlighted by researchers including Rhonda Patrick for potential immune and antiviral support.
Vitamin C may help regenerate quercetin from its oxidized form and the two compounds share complementary antioxidant and anti-inflammatory pathways.
Bromelain is included in some commercial quercetin formulations (e.g., with vitamin C) with the rationale that it may enhance quercetin absorption and add complementary anti-inflammatory activity.
Both are polyphenols with overlapping anti-inflammatory, antioxidant, and potential senolytic properties; they are frequently co-studied in the context of cardiovascular health and aging.
Safety & interactions
Quercetin is generally considered safe at supplemental doses up to approximately 1000 mg/day in short-term human studies, with a long history of dietary exposure; very high doses or prolonged use warrant caution, and safety reviews note the importance of using tested, reputable formulations given variability in product quality.
- •May inhibit CYP3A4 and CYP2C8 enzymes, potentially increasing plasma levels of certain medications metabolized by these pathways (e.g., some statins, cyclosporine, certain anticoagulants)
- •May have additive effects with antihypertensive medications — meta-analysis data suggest modest blood pressure-lowering effects
- •Potential interaction with antibiotics (e.g., fluoroquinolones) due to structural similarity; timing separation may be advisable
- •May affect thyroid hormone metabolism at high doses — caution in individuals on thyroid medications
Individuals who are pregnant or breastfeeding should exercise caution due to insufficient safety data; those on immunosuppressants (e.g., cyclosporine), anticoagulants, or medications with narrow therapeutic windows should consult a healthcare provider before use due to potential CYP-mediated drug interactions; people with kidney disease should be cautious at high doses.